Correlation Between Tff Pharmaceuticals and Elutia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Elutia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Elutia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Elutia Inc, you can compare the effects of market volatilities on Tff Pharmaceuticals and Elutia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Elutia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Elutia.

Diversification Opportunities for Tff Pharmaceuticals and Elutia

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tff and Elutia is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Elutia Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elutia Inc and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Elutia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elutia Inc has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Elutia go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Elutia

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Elutia. In addition to that, Tff Pharmaceuticals is 2.8 times more volatile than Elutia Inc. It trades about -0.28 of its total potential returns per unit of risk. Elutia Inc is currently generating about 0.23 per unit of volatility. If you would invest  319.00  in Elutia Inc on September 2, 2024 and sell it today you would earn a total of  95.00  from holding Elutia Inc or generate 29.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tff Pharmaceuticals  vs.  Elutia Inc

 Performance 
       Timeline  
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Elutia Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Elutia Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Elutia may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Tff Pharmaceuticals and Elutia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tff Pharmaceuticals and Elutia

The main advantage of trading using opposite Tff Pharmaceuticals and Elutia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Elutia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elutia will offset losses from the drop in Elutia's long position.
The idea behind Tff Pharmaceuticals and Elutia Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device